消費者直結臨床検査の北米市場2021年ｰ2031年：検体タイプ別（血液、尿、唾液、その他）、検査タイプ別、エンドユーザー別

• 英文タイトル：Direct-to-Consumer Laboratory Testing Market (Sample Type: Blood, Urine, Saliva, and Others; Test Type: Genetic Testing, Disease Risk Assessment Testing, Complete Blood Count [CBC], Diabetes Testing, TSH Testing, and Others; and End-user: Hospitals, Clinics, Specialty Labs, and Diagnostic Centers) - North America Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

• レポートコード：TMR2112A057 • 出版社/出版日：Transparency Market Research / 2021年10月13日 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール • 産業分類：医療

• 販売価格（消費税別）

Single User	￥857,660 (USD5,795)	▷ お問い合わせ
Site Licence	￥1,301,660 (USD8,795)	▷ お問い合わせ
Enterprisewide	￥1,745,660 (USD11,795)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

Transparency Market Research社の本調査レポートは、消費者直結臨床検査の北米市場を調査対象とし、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、検体タイプ別分析、検査タイプ別分析、エンドユーザー別分析、国別分析、競争状況などの構成でまとめております。

North America Direct-to-Consumer Laboratory Testing Market – Scope of Report
The latest study collated and published by Transparency Market Research (TMR) analyzes the historical and present scenario of the direct-to-consumer laboratory testing market in North America to gauge its growth potential. The study presents detailed information about key growth factors, restraints, and trends that are creating the landscape for growth of the direct-to-consumer laboratory testing market in North America in order to identify opportunities for stakeholders. The report also provides insightful information about the growth of the direct-to-consumer laboratory testing market in North America during the forecast period from 2021 to 2031.

The report offers intricate dynamics about different aspects of the direct-to-consumer laboratory testing market, which aids companies operating in the market in making strategic decisions. TMR’s study also elaborates on the significant changes that are anticipated to drive the direct-to-consumer laboratory testing market in North America during the forecast period. It also includes key indicators of growth of the direct-to-consumer laboratory testing market in the region and estimates statistics related to the market and value (US$ Mn).

This study covers detailed segmentation of the direct-to-consumer laboratory testing market in North America, along with key information and competition outlook. The report provides company profiles of players that are currently dominating the market, wherein various development, expansion, and winning strategies practiced by these players have been presented in detail.

Key Questions Answered in TMR’s Report on North America Direct-to-Consumer Laboratory Testing Market

The report provides detailed information about the direct-to-consumer laboratory testing market in North America based on a comprehensive research on various factors that play a key role in accelerating the growth of the market. Information provided in the report answers path-breaking questions for companies that are currently operating in the direct-to-consumer laboratory testing market in North America and are looking for innovative methods to create a unique benchmark in the market to help them design successful strategies and make target-driven decisions.

Which segment of the direct-to-consumer laboratory testing market in North America will emerge as a major revenue generator during the forecast period?
How are key market players successfully earning revenue in the direct-to-consumer laboratory testing market in North America?
What would be the Y-o-Y growth of the direct-to-consumer laboratory testing market in North America between 2021 and 2031?
What are the winning imperatives of leading players operating in the direct-to-consumer laboratory testing market in North America?

Research Methodology – North America Direct-to-Consumer Laboratory Testing Market

The research methodology adopted by analysts for compiling the report on the direct-to-consumer laboratory testing market in North America is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information obtained and legitimated by market-admissible sources, analysts have offered observations and authentic forecasts of the direct-to-consumer laboratory testing market in North America.

During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the direct-to-consumer laboratory testing market in North America.

For secondary research, analysts have scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the direct-to-consumer laboratory testing market in North America.

レポート目次

---

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: North America Direct-to-Consumer Laboratory Testing Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. North America Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Porter’s Five Force Analysis
5. Key Insights
5.1. Key Industrial Events (Licensing Partnership/Merger & Acquisition)
5.2. Disease Prevalence & Incidence Rate
5.3. Regulatory Scenario
5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. North America Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, by Sample Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Sample Type, 2017–2031
6.3.1. Blood
6.3.2. Urine
6.3.3. Saliva
6.3.4. Others
6.4. Market Attractiveness Analysis, by Sample Type
7. North America Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, by Test Type
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Test Type, 2017–2031
7.3.1. Genetic Testing
7.3.2. Disease Risk Assessment Testing
7.3.2.1. Cancer
7.3.2.2. STDs
7.3.2.3. Others
7.3.3. CBC
7.3.4. Diabetes testing
7.3.5. TSH testing
7.3.6. Others
7.4. Market Attractiveness Analysis, by Test Type
8. North America Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast by End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Clinics
8.3.3. Specialty Labs
8.3.4. Diagnostic Centers
8.4. Market Attractiveness Analysis, by End-user
9. North America Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, by Country
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. U.S.
9.2.2. Canada
9.3. Market Attractiveness Analysis, by Country
10. Competition Landscape
10.1. Market Player – Competition Matrix (by tier and size of companies)
10.2. Market Share Analysis, by Company, 2020
10.3. Company Profiles
10.3.1. Quest Diagnostics Incorporated
10.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
10.3.1.2. Product Portfolio
10.3.1.3. Strategic Overview
10.3.1.4. SWOT Analysis
10.3.2. Laboratory Corporation of America Holdings
10.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
10.3.2.2. Product Portfolio
10.3.2.3. Strategic Overview
10.3.2.4. SWOT Analysis
10.3.3. 23andMe, Inc.
10.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
10.3.3.2. Product Portfolio
10.3.3.3. Strategic Overview
10.3.3.4. SWOT Analysis
10.3.4. ANY LAB TEST NOW
10.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
10.3.4.2. Product Portfolio
10.3.4.3. Strategic Overview
10.3.4.4. SWOT Analysis
10.3.5. Direct Labs LLC
10.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
10.3.5.2. Product Portfolio
10.3.5.3. Strategic Overview
10.3.5.4. SWOT Analysis
10.3.6. Everlywell
10.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
10.3.6.2. Product Portfolio
10.3.6.3. Strategic Overview
10.3.6.4. SWOT Analysis
10.3.7. MyMedLab
10.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
10.3.7.2. Product Portfolio
10.3.7.3. Strategic Overview
10.3.7.4. SWOT Analysis
10.3.8. ColorGenomics
10.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
10.3.8.2. Product Portfolio
10.3.8.3. Strategic Overview
10.3.8.4. SWOT Analysis
10.3.9. Ancestry
10.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
10.3.9.2. Product Portfolio
10.3.9.3. Strategic Overview
10.3.9.4. SWOT Analysis
10.3.10. WellnessFX
10.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
10.3.10.2. Product Portfolio
10.3.10.3. Strategic Overview
10.3.10.4. SWOT Analysis
10.3.11. LetsGetChecked
10.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
10.3.11.2. Product Portfolio
10.3.11.3. Strategic Overview
10.3.11.4. SWOT Analysis
10.3.12. Other Prominent Players
10.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
10.3.12.2. Product Portfolio
10.3.12.3. Strategic Overview
10.3.12.4. SWOT Analysis

List of Tables

Table 01: North America Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 02: North America Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

Table 03: North America Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 04: North America Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk Assessment Testing, 2017–2031

Table 05: North America Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2031

---